Vytrus Biotech (FRA:V5P) Days Payable: 0.00 (As of Dec. 2025)


FRA:V5P Vytrus Biotech SA FRA:V5P
63 GF Score
Price €16.70
GF Value €6.81
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Vytrus Biotech Days Payable?

Vytrus Biotech FRA:V5P -2.34% 63 Days Payable is 0.00 as of Dec. 2025. GuruFocus rates FRA:V5P with a GF Score™ of 63/100 and a GF Value™ of €6.81 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 701 Biotechnology companies, Vytrus Biotech ranks worse than 142653.21% on this metric.

Vytrus Biotech's average Accounts Payable for the six months ended in Dec. 2025 was €0.07 Mil. Vytrus Biotech's Cost of Goods Sold for the six months ended in Dec. 2025 was €-0.24 Mil.

The historical rank and industry rank for Vytrus Biotech's Days Payable or its related term are showing as below:

FRA:V5P's Days Payable is not ranked *
in the Biotechnology industry.
Industry Median: 112.84
* Ranked among companies with meaningful Days Payable only.

Vytrus Biotech's Days Payable stayed the same from Dec. 2024 (0.00) to Dec. 2025 (0.00).

Vytrus Biotech Days Payable Historical Data

* Premium members only.

The historical data trend for Vytrus Biotech's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vytrus Biotech Days Payable Chart

Vytrus Biotech Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Payable
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Vytrus Biotech Semi-Annual Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FRA:V5P vs VRTX, REGN, ALNY: Days Payable Comparison

For the Biotechnology subindustry, Vytrus Biotech's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vytrus Biotech Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vytrus Biotech's Days Payable distribution charts can be found below:

* The bar in red indicates where Vytrus Biotech's Days Payable falls into.


FRA:V5P
63GF Score
Vytrus Biotech SA FRA:V5P
Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vytrus Biotech Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Vytrus Biotech's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as

Days Payable (A: Dec. 2025 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2024 ) + Accounts Payable (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (0.098 + 0.048) / 2 ) / -0.458*365
=0.073 / -0.458*365
=N/A

Vytrus Biotech's Days Payable for the quarter that ended in Dec. 2025 is calculated as:

Days Payable (Q: Dec. 2025 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Jun. 2025 ) + Accounts Payable (Q: Dec. 2025 )) / count ) / Cost of Goods Sold (Q: Dec. 2025 )*Days in Period
=( (0.092 + 0.048) / 2 ) / -0.244*365 / 2
=0.07 / -0.244*365 / 2
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 0.00 mean?
Vytrus Biotech (FRA:V5P) has a Days Payable of 0.00 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Vytrus Biotech and its competitors. According to the industry distribution chart, Vytrus Biotech ranks #999999 out of 701 companies in the Biotechnology industry.
Is Vytrus Biotech's Days Payable too high?
Vytrus Biotech's current Days Payable is 0.00. Based on the distribution chart, Vytrus Biotech ranks #999999 out of 701 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Vytrus Biotech has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vytrus Biotech's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Vytrus Biotech ranks #999999 out of 701 companies for Days Payable. This places Vytrus Biotech in the lower half of its industry. The industry median Days Payable is 112.84. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 112.84, based on 701 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Vytrus Biotech and its competitors. For the Biotechnology industry, the median Days Payable is 112.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vytrus Biotech's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vytrus Biotech stock overvalued right now?
Based on GuruFocus' analysis, Vytrus Biotech (FRA:V5P) is currently considered Significantly Overvalued. The stock's GF Value™ is €6.81, compared to a current price of €16.70 — trading 145.2% above its estimated fair value. The current Days Payable is 0.00. Vytrus Biotech's overall GF Score™ is 63/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Vytrus Biotech (FRA:V5P), the current Days Payable is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vytrus Biotech (FRA:V5P) Overvalued in 2026?

Based on GuruFocus' analysis, Vytrus Biotech stock appears to be overvalued. The current stock price of €16.70 is trading 145.2% above its estimated GF Value™ of €6.81. GuruFocus considers Vytrus Biotech to be Significantly Overvalued.

Key valuation signals for FRA:V5P:

  • Days Payable: 0.00
  • GF Value™: €6.81 vs. price of €16.70 (145.2% above fair value)
  • GF Score™: 63/100 with 2 warning signs

No single metric tells the full story. See the FRA:V5P stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vytrus Biotech Business Description

Other Exchanges VYT:Spain
Address Sant Gaieta 121, 2nd Floor, Terrassa, Barcelona, ESP, 08221
Vytrus Biotech SA develops natural active ingredients on an industrial scale. The natural actives offered by the company include Nectaria Lithops, Olea Vitae, Turmeric zen, Capilia Longa, Qura Noni.
63GF Score

Get the complete analysis for FRA:V5P

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€16.70
Price
€6.81
GF Value